Upstream Bio (UPB) Total Liabilities: 2023-2025
Historic Total Liabilities for Upstream Bio (UPB) over the last 2 years, with Sep 2025 value amounting to $12.6 million.
- Upstream Bio's Total Liabilities rose 3.91% to $12.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.6 million, marking a year-over-year increase of 3.91%. This contributed to the annual value of $11.9 million for FY2024, which is 26.39% up from last year.
- Upstream Bio's Total Liabilities amounted to $12.6 million in Q3 2025, which was up 7.07% from $11.8 million recorded in Q2 2025.
- Over the past 5 years, Upstream Bio's Total Liabilities peaked at $146.6 million during Q2 2024, and registered a low of $9.4 million during Q4 2023.
- In the last 3 years, Upstream Bio's Total Liabilities had a median value of $12.1 million in 2024 and averaged $51.2 million.
- In the last 5 years, Upstream Bio's Total Liabilities climbed by 26.39% in 2024 and then crashed by 92.09% in 2025.
- Quarterly analysis of 3 years shows Upstream Bio's Total Liabilities stood at $9.4 million in 2023, then grew by 26.39% to $11.9 million in 2024, then climbed by 3.91% to $12.6 million in 2025.
- Its Total Liabilities stands at $12.6 million for Q3 2025, versus $11.8 million for Q2 2025 and $10.6 million for Q1 2025.